Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Patrick Johnston

Concepts (729)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
59
2026
193
11.440
Why?
Lymphoma, Non-Hodgkin
38
2026
124
6.920
Why?
Hematopoietic Stem Cell Transplantation
35
2026
699
4.910
Why?
Visual Perception
7
2025
184
3.140
Why?
Antineoplastic Combined Chemotherapy Protocols
47
2026
1963
3.110
Why?
Transplantation, Autologous
34
2026
300
3.040
Why?
Lymphoma
18
2024
237
2.640
Why?
Immunotherapy, Adoptive
23
2026
342
2.450
Why?
Hodgkin Disease
18
2026
171
2.360
Why?
Salvage Therapy
13
2024
165
2.290
Why?
Lymphoma, B-Cell
16
2026
140
2.220
Why?
Neoplasm Recurrence, Local
25
2026
1149
2.130
Why?
Antigens, CD19
12
2024
128
2.120
Why?
Central Nervous System Neoplasms
11
2026
177
2.110
Why?
Reaction Time
6
2025
433
1.830
Why?
Visual Cortex
2
2025
84
1.600
Why?
Rituximab
28
2025
210
1.420
Why?
Lymphoma, Follicular
13
2025
56
1.400
Why?
Biological Products
9
2023
257
1.150
Why?
Aged
122
2026
26153
1.130
Why?
Everolimus
11
2018
112
1.040
Why?
Adult
128
2026
40777
1.030
Why?
Middle Aged
132
2026
36215
1.030
Why?
Humans
235
2026
145475
0.990
Why?
Male
152
2026
72843
0.930
Why?
Retrospective Studies
63
2026
17291
0.930
Why?
Granulocyte Colony-Stimulating Factor
5
2021
90
0.920
Why?
Aged, 80 and over
61
2026
8333
0.910
Why?
Young Adult
55
2026
14219
0.890
Why?
Lymphocytes
9
2026
376
0.890
Why?
Evoked Potentials
4
2025
131
0.870
Why?
Female
145
2026
78845
0.860
Why?
Prognosis
45
2026
4316
0.790
Why?
Disease-Free Survival
29
2023
767
0.790
Why?
Monocytes
9
2019
539
0.730
Why?
Antineoplastic Agents
18
2021
2214
0.710
Why?
Photic Stimulation
5
2025
263
0.710
Why?
Attention
2
2025
461
0.700
Why?
Fluorodeoxyglucose F18
8
2024
161
0.690
Why?
Peripheral Blood Stem Cell Transplantation
10
2015
35
0.690
Why?
Waldenstrom Macroglobulinemia
5
2023
20
0.690
Why?
Lymphocyte Count
17
2022
164
0.690
Why?
Sirolimus
6
2015
280
0.680
Why?
Recurrence
17
2024
1138
0.670
Why?
Lymphoma, Mantle-Cell
6
2022
36
0.660
Why?
Brain Mapping
6
2022
538
0.660
Why?
Cyclophosphamide
15
2025
270
0.650
Why?
Electroencephalography
6
2025
561
0.640
Why?
Radiopharmaceuticals
6
2021
205
0.620
Why?
Neurotoxicity Syndromes
4
2023
40
0.590
Why?
Multiple Myeloma
7
2023
309
0.580
Why?
Treatment Outcome
41
2026
11772
0.580
Why?
Doxorubicin
13
2025
401
0.560
Why?
Retinal Neoplasms
5
2018
37
0.560
Why?
Vincristine
11
2025
142
0.550
Why?
Retinal Detachment
6
2009
73
0.550
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
5
2021
76
0.550
Why?
Survival Rate
21
2021
2090
0.530
Why?
Spatial Processing
1
2017
1
0.510
Why?
Neoplasms, Second Primary
2
2017
102
0.500
Why?
Time Perception
1
2017
31
0.490
Why?
Prednisone
10
2025
224
0.490
Why?
Positron-Emission Tomography
7
2024
343
0.490
Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
95
0.470
Why?
Combined Modality Therapy
9
2024
1266
0.470
Why?
Brain
7
2021
2947
0.460
Why?
Methotrexate
4
2025
233
0.460
Why?
Cell Transformation, Neoplastic
5
2019
337
0.450
Why?
Transplantation Conditioning
10
2015
191
0.450
Why?
Drug Resistance, Neoplasm
8
2025
881
0.440
Why?
Face
1
2016
174
0.440
Why?
Stem Cell Transplantation
7
2021
189
0.440
Why?
Antibodies, Monoclonal
9
2017
1505
0.430
Why?
Vitreous Body
7
2018
117
0.430
Why?
Piperidines
5
2022
222
0.420
Why?
Survival Analysis
19
2021
1374
0.410
Why?
Antineoplastic Agents, Immunological
3
2021
198
0.410
Why?
Autografts
6
2022
55
0.410
Why?
Follow-Up Studies
24
2025
5423
0.400
Why?
Synovial Cyst
1
2013
4
0.380
Why?
Positron Emission Tomography Computed Tomography
4
2023
117
0.380
Why?
Amyloidosis
4
2018
44
0.370
Why?
Pyrimidines
6
2025
530
0.360
Why?
Antigens, CD20
5
2017
34
0.360
Why?
Wrist
1
2013
60
0.360
Why?
Lymphoma, B-Cell, Marginal Zone
3
2022
19
0.360
Why?
Fingers
1
2013
107
0.360
Why?
Pyrazoles
5
2022
517
0.360
Why?
Radioimmunotherapy
4
2017
25
0.350
Why?
Lymphoma, T-Cell
3
2015
29
0.330
Why?
Eye Neoplasms
5
2014
30
0.320
Why?
Protein-Tyrosine Kinases
3
2009
431
0.310
Why?
Adolescent
34
2026
22530
0.310
Why?
Orthopedic Procedures
1
2013
244
0.310
Why?
Lasers, Solid-State
1
2009
22
0.290
Why?
Neoplasm Proteins
4
2019
441
0.290
Why?
Burkitt Lymphoma
3
2022
61
0.280
Why?
Neoplasm Staging
12
2020
1471
0.280
Why?
Cataract Extraction
2
2009
120
0.280
Why?
Molecular Targeted Therapy
2
2010
439
0.280
Why?
Magnetic Resonance Imaging
10
2026
3904
0.270
Why?
Kaplan-Meier Estimate
12
2018
969
0.270
Why?
Risk Factors
23
2022
10885
0.270
Why?
Thalidomide
3
2018
43
0.260
Why?
Mechanistic Target of Rapamycin Complex 1
4
2018
138
0.260
Why?
Killer Cells, Natural
4
2023
480
0.260
Why?
Dexamethasone
6
2022
365
0.250
Why?
Hematopoietic Stem Cell Mobilization
3
2012
28
0.250
Why?
Pattern Recognition, Visual
2
2025
104
0.250
Why?
Lymphoma, T-Cell, Peripheral
2
2024
20
0.240
Why?
Transfusion Reaction
1
2006
61
0.240
Why?
Castleman Disease
1
2026
16
0.240
Why?
TOR Serine-Threonine Kinases
4
2017
454
0.240
Why?
Chemoradiotherapy
2
2021
239
0.230
Why?
Fracture Fixation
1
2006
80
0.230
Why?
Circulating Tumor DNA
1
2026
46
0.230
Why?
RNA, Small Interfering
2
2007
637
0.230
Why?
Hip Fractures
1
2006
87
0.230
Why?
Peripheral Nervous System Neoplasms
1
2025
19
0.220
Why?
Adaptation, Physiological
2
2022
560
0.220
Why?
Event-Related Potentials, P300
1
2025
16
0.220
Why?
Eye Injuries
3
1991
53
0.220
Why?
B-Lymphocytes
6
2023
870
0.220
Why?
Central Nervous System
3
2023
282
0.210
Why?
Thrombocytopenia
3
2022
204
0.210
Why?
Medical Oncology
2
2026
339
0.210
Why?
Skin Neoplasms
2
2022
849
0.210
Why?
Lymphohistiocytosis, Hemophagocytic
1
2024
29
0.210
Why?
Acute Kidney Injury
2
2022
875
0.210
Why?
Perioperative Care
1
2006
231
0.200
Why?
Appendicitis
1
2026
150
0.200
Why?
Conditioning, Classical
2
2022
119
0.200
Why?
Mediastinal Neoplasms
1
2024
53
0.200
Why?
Cancer Vaccines
1
2025
161
0.200
Why?
Hepatitis A
1
2024
25
0.200
Why?
Multiprotein Complexes
3
2017
172
0.200
Why?
Aqueous Humor
2
2014
38
0.200
Why?
Fear
2
2022
368
0.200
Why?
Incidence
9
2024
2923
0.200
Why?
Orientation
1
2023
50
0.190
Why?
Immunoglobulin kappa-Chains
2
2014
23
0.190
Why?
Hydroxamic Acids
2
2014
94
0.190
Why?
Standard of Care
4
2025
81
0.190
Why?
Predictive Value of Tests
11
2018
2121
0.190
Why?
Immunologic Factors
3
2014
260
0.190
Why?
Prospective Studies
15
2025
8057
0.190
Why?
Extinction, Psychological
2
2022
92
0.190
Why?
Venous Thromboembolism
2
2022
328
0.190
Why?
Cell- and Tissue-Based Therapy
4
2024
78
0.190
Why?
Cerebellum
2
2017
224
0.180
Why?
Facial Expression
1
2023
75
0.180
Why?
Vitamin D Deficiency
2
2017
190
0.180
Why?
Tomography, X-Ray Computed
4
2016
2769
0.180
Why?
Yttrium Radioisotopes
4
2017
63
0.180
Why?
Electromyography
1
2024
419
0.180
Why?
Carmustine
2
2020
52
0.180
Why?
Brain Diseases
1
2023
155
0.180
Why?
Transcription Factors
1
2010
1734
0.180
Why?
Bortezomib
4
2018
54
0.170
Why?
Myeloid Differentiation Factor 88
2
2019
119
0.170
Why?
Immunoglobulin Light Chains
3
2013
52
0.170
Why?
Facial Recognition
1
2022
35
0.170
Why?
Cohort Studies
13
2026
6013
0.170
Why?
Magnesium Deficiency
1
2021
2
0.170
Why?
Central Nervous System Diseases
1
2022
74
0.170
Why?
Status Epilepticus
1
2022
68
0.170
Why?
Hypoalbuminemia
1
2021
27
0.170
Why?
Measles virus
3
2010
21
0.170
Why?
Fluorine Radioisotopes
1
2021
14
0.170
Why?
Immunoconjugates
1
2022
138
0.170
Why?
Space Perception
1
2021
82
0.160
Why?
Bacterial Infections
1
2023
246
0.160
Why?
Magnesium
1
2021
156
0.160
Why?
Autism Spectrum Disorder
2
2017
422
0.160
Why?
Vision, Ocular
1
2020
47
0.160
Why?
Cytokines
4
2021
2067
0.160
Why?
Schizophrenia
2
2017
453
0.160
Why?
Antigens, CD34
2
2010
89
0.160
Why?
Testis
1
2021
162
0.160
Why?
Medication Systems
1
2000
3
0.160
Why?
Molecular Epidemiology
2
2017
73
0.150
Why?
Filgrastim
2
2017
13
0.150
Why?
Heterocyclic Compounds
2
2012
23
0.150
Why?
Autoimmunity
2
2018
933
0.150
Why?
Retinal Perforations
3
1996
18
0.150
Why?
Lymphopenia
2
2010
62
0.150
Why?
Automation
1
2000
104
0.150
Why?
Leukemia, B-Cell
1
2019
12
0.150
Why?
Nursing Staff
1
2000
40
0.150
Why?
Melphalan
4
2017
43
0.150
Why?
Leg
1
2021
242
0.150
Why?
Drug Administration Schedule
8
2017
782
0.150
Why?
Cost-Benefit Analysis
1
2022
639
0.150
Why?
Proportional Hazards Models
7
2023
1327
0.150
Why?
Recombinant Proteins
3
2017
1368
0.150
Why?
Enterocolitis, Necrotizing
2
2010
41
0.140
Why?
Protein Kinase Inhibitors
4
2019
981
0.140
Why?
Cues
1
2021
327
0.140
Why?
Infusions, Parenteral
1
2018
48
0.140
Why?
Time Factors
12
2019
7123
0.140
Why?
Leukocyte Count
3
2014
316
0.140
Why?
Vidarabine
4
2017
32
0.140
Why?
Mental Recall
1
2020
222
0.140
Why?
Janus Kinase 1
1
2018
26
0.140
Why?
Child
16
2026
22707
0.140
Why?
Myeloid-Derived Suppressor Cells
1
2019
76
0.140
Why?
Mutation, Missense
1
2019
335
0.130
Why?
Autistic Disorder
2
2011
219
0.130
Why?
Drug Approval
2
2010
93
0.130
Why?
Leukapheresis
2
2016
27
0.130
Why?
Thrombosis
1
2022
400
0.130
Why?
Northern Ireland
5
2009
12
0.130
Why?
Class I Phosphatidylinositol 3-Kinases
1
2018
108
0.130
Why?
Contingent Negative Variation
1
2017
9
0.130
Why?
Immunoglobulin lambda-Chains
2
2014
9
0.130
Why?
Postoperative Complications
2
2006
2970
0.130
Why?
Waste Disposal, Fluid
1
2017
52
0.130
Why?
Delay Discounting
1
2017
29
0.130
Why?
Immunotherapy
2
2019
666
0.130
Why?
Lipopolysaccharide Receptors
1
2017
88
0.130
Why?
Visual Fields
2
2017
116
0.130
Why?
Evoked Potentials, Visual
1
2017
42
0.130
Why?
Immunophenotyping
2
2015
319
0.120
Why?
Fluorouracil
2
2016
231
0.120
Why?
Maximum Tolerated Dose
4
2019
210
0.120
Why?
Tarsal Coalition
1
2016
1
0.120
Why?
Subtalar Joint
1
2016
5
0.120
Why?
Evoked Potentials, Auditory
1
2017
181
0.120
Why?
Magnetoencephalography
1
2017
161
0.120
Why?
Visual Acuity
4
1996
491
0.120
Why?
Glycine
1
2017
186
0.120
Why?
Case-Control Studies
6
2021
3623
0.120
Why?
Time-to-Treatment
1
2018
251
0.110
Why?
Mental Processes
1
2015
37
0.110
Why?
Uveitis
2
2014
149
0.110
Why?
Body Fluids
1
1996
71
0.110
Why?
Biomarkers
6
2023
4295
0.110
Why?
Dendritic Cells
1
2019
499
0.110
Why?
Odds Ratio
4
2018
1082
0.110
Why?
Antipsychotic Agents
1
2017
211
0.110
Why?
Hemangioma, Capillary
1
1995
14
0.110
Why?
Outpatients
1
2018
447
0.110
Why?
Environmental Monitoring
1
2017
346
0.110
Why?
Myelodysplastic Syndromes
1
2017
165
0.110
Why?
Lymphoma, Large-Cell, Immunoblastic
1
2014
1
0.110
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
261
0.110
Why?
Comprehension
1
2017
186
0.110
Why?
Folic Acid
1
2016
198
0.110
Why?
United States
6
2025
16098
0.110
Why?
Psychotic Disorders
1
2017
189
0.110
Why?
Boronic Acids
2
2014
36
0.110
Why?
Polyethylene Glycols
2
2017
649
0.110
Why?
Interleukin-10
2
2013
309
0.110
Why?
Translocation, Genetic
2
2022
119
0.100
Why?
Obsessive-Compulsive Disorder
1
2015
60
0.100
Why?
Optic Disk
1
1995
53
0.100
Why?
Task Performance and Analysis
1
2015
198
0.100
Why?
Water Pollutants, Chemical
1
2017
227
0.100
Why?
Prefrontal Cortex
1
2017
334
0.100
Why?
Biomarkers, Tumor
4
2013
1321
0.100
Why?
Neoplasms
2
2022
2906
0.100
Why?
Myeloid Cells
1
2015
147
0.100
Why?
Pyrazines
2
2014
94
0.100
Why?
Autoimmune Diseases
2
2018
468
0.100
Why?
Heart Atria
1
2014
141
0.100
Why?
Feasibility Studies
2
2016
1111
0.100
Why?
Polyneuropathies
1
2013
57
0.100
Why?
Intestinal Neoplasms
1
2013
30
0.100
Why?
Indoles
2
2014
507
0.100
Why?
Intestinal Perforation
1
2013
46
0.100
Why?
Oligodeoxyribonucleotides
1
2013
141
0.090
Why?
Tachycardia, Supraventricular
1
2013
49
0.090
Why?
Retinal Neovascularization
1
1993
29
0.090
Why?
Quality Assurance, Health Care
2
2008
342
0.090
Why?
Remission Induction
4
2017
307
0.090
Why?
T-Lymphocytes
3
2018
1996
0.090
Why?
POEMS Syndrome
1
2012
3
0.090
Why?
Peripheral Nerves
1
2013
72
0.090
Why?
Programmed Cell Death 1 Receptor
1
2014
265
0.090
Why?
Scleral Diseases
1
1992
2
0.090
Why?
Anti-Bacterial Agents
2
2023
1923
0.090
Why?
Hematologic Neoplasms
2
2013
168
0.090
Why?
Cell Proliferation
3
2015
2507
0.090
Why?
Disease Progression
6
2021
2864
0.090
Why?
Carbonated Beverages
1
1991
16
0.090
Why?
Corneal Diseases
1
1992
46
0.090
Why?
Epidermolysis Bullosa Dystrophica
1
1992
41
0.090
Why?
Child, Preschool
6
2026
11853
0.090
Why?
Soft Tissue Neoplasms
1
2013
131
0.090
Why?
Attitude of Health Personnel
1
2000
1193
0.080
Why?
Gene Expression Profiling
2
2011
1767
0.080
Why?
Sensitivity and Specificity
4
2026
1997
0.080
Why?
Stomach Neoplasms
1
2013
128
0.080
Why?
Contrast Media
2
2026
497
0.080
Why?
Disease Management
2
2026
653
0.080
Why?
Oncolytic Virotherapy
1
2010
13
0.080
Why?
Blast Injuries
1
1991
62
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
2
2022
239
0.080
Why?
Oncolytic Viruses
1
2010
8
0.080
Why?
Gene Targeting
1
2010
81
0.080
Why?
Samarium
1
2010
1
0.080
Why?
Myeloablative Agonists
1
2010
23
0.080
Why?
Cornea
1
1992
154
0.080
Why?
Arrhythmias, Cardiac
1
2013
355
0.080
Why?
X-Ray Intensifying Screens
1
2010
3
0.080
Why?
Miosis
1
1990
4
0.080
Why?
Radioisotopes
1
2010
37
0.080
Why?
Gray Matter
1
2011
92
0.080
Why?
Self Report
1
2015
870
0.080
Why?
Immunosuppressive Agents
1
2015
838
0.080
Why?
Short Bowel Syndrome
1
2010
27
0.080
Why?
Gene Expression Regulation, Neoplastic
2
2014
1443
0.080
Why?
Leukemia, Myeloid, Acute
1
2017
686
0.080
Why?
Surveys and Questionnaires
3
2022
6066
0.080
Why?
Holidays
1
2009
8
0.080
Why?
Child Development Disorders, Pervasive
1
2010
65
0.080
Why?
Indomethacin
1
1990
76
0.080
Why?
Radiometry
1
2010
56
0.080
Why?
Minnesota
4
2013
168
0.080
Why?
Oxazines
1
2009
37
0.080
Why?
Electronics
1
2010
65
0.080
Why?
Iris Diseases
1
1989
7
0.080
Why?
Interleukin-15
1
2010
95
0.080
Why?
Subtraction Technique
1
2009
26
0.080
Why?
Uveal Neoplasms
1
1989
16
0.070
Why?
Pain Threshold
1
2009
72
0.070
Why?
Severity of Illness Index
4
2015
2930
0.070
Why?
Organophosphorus Compounds
1
2010
84
0.070
Why?
Organometallic Compounds
1
2010
113
0.070
Why?
Lenses, Intraocular
1
1989
49
0.070
Why?
Quinolones
1
2011
203
0.070
Why?
Fatigue
2
2024
364
0.070
Why?
Radiation Dosage
1
2010
193
0.070
Why?
Chromosomes, Human, Pair 6
1
2008
46
0.070
Why?
Multivariate Analysis
5
2012
1547
0.070
Why?
Marijuana Abuse
1
2011
213
0.070
Why?
Neurons
2
2009
1649
0.070
Why?
Double-Blind Method
3
2019
2062
0.070
Why?
Treatment Failure
2
2024
360
0.070
Why?
Hospitalization
1
2018
2460
0.070
Why?
Gases
1
1988
46
0.070
Why?
Amygdala
1
2009
199
0.070
Why?
Vancomycin Resistance
1
2007
16
0.070
Why?
Fluorescein Angiography
3
1996
190
0.070
Why?
Down-Regulation
2
2007
618
0.070
Why?
Ambulatory Surgical Procedures
1
2008
79
0.070
Why?
Ophthalmoplegia
1
1987
13
0.070
Why?
Enterococcus
1
2007
22
0.070
Why?
Germinal Center
1
2008
64
0.070
Why?
Torticollis
1
1987
17
0.070
Why?
Cytarabine
3
2017
66
0.070
Why?
Obesity
1
2021
3116
0.070
Why?
Chromosomes, Human, Pair 2
1
2007
28
0.060
Why?
Chromosomes, Human, Pair 5
1
2007
28
0.060
Why?
Models, Neurological
1
2009
250
0.060
Why?
Rhinoplasty
1
2008
39
0.060
Why?
Logistic Models
4
2018
2134
0.060
Why?
Infant, Premature, Diseases
1
2008
113
0.060
Why?
Carrier State
1
2007
78
0.060
Why?
Proto-Oncogene Proteins c-bcl-6
2
2022
11
0.060
Why?
Temporal Lobe
2
2022
105
0.060
Why?
Emotions
2
2023
574
0.060
Why?
Immunohistochemistry
5
2012
1716
0.060
Why?
Atrial Fibrillation
1
2013
558
0.060
Why?
Vitamin D
1
2010
403
0.060
Why?
Ki-1 Antigen
1
2006
7
0.060
Why?
Flow Cytometry
4
2015
1162
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2009
456
0.060
Why?
Prosthesis Implantation
1
2008
154
0.060
Why?
Radiotherapy Dosage
2
2021
288
0.060
Why?
Diagnosis, Differential
2
2026
1508
0.060
Why?
Proto-Oncogene Proteins c-jun
1
2006
54
0.060
Why?
Seat Belts
1
1986
23
0.060
Why?
Quality of Life
3
2023
3204
0.060
Why?
Eye
1
2007
112
0.060
Why?
Behavior, Animal
1
2009
519
0.060
Why?
Reproducibility of Results
4
2015
3413
0.060
Why?
ROC Curve
2
2023
617
0.060
Why?
Lymphocyte Depletion
1
2006
132
0.060
Why?
Lens, Crystalline
1
1987
136
0.060
Why?
Cerebral Cortex
1
2009
473
0.060
Why?
Anemia
2
2018
191
0.060
Why?
Hematopoietic Stem Cells
2
2010
435
0.060
Why?
Neoplasm, Residual
1
2026
143
0.060
Why?
Signal Transduction
2
2010
5216
0.060
Why?
Isoquinolines
1
2025
43
0.060
Why?
Pyridines
1
2009
609
0.060
Why?
Melanoma
2
1989
759
0.060
Why?
Retreatment
2
2017
79
0.060
Why?
Amyloid
1
2006
94
0.050
Why?
Cross Infection
1
2007
260
0.050
Why?
Risk Assessment
4
2018
3747
0.050
Why?
Pregnanolone
1
2005
34
0.050
Why?
Neoplasm Grading
2
2018
310
0.050
Why?
Induction Chemotherapy
1
2025
88
0.050
Why?
Cisplatin
2
2022
345
0.050
Why?
Thiophenes
1
2025
117
0.050
Why?
Cognition
2
2024
1266
0.050
Why?
Algorithms
1
2012
1845
0.050
Why?
Vitrectomy
2
2013
73
0.050
Why?
Aminopterin
1
2024
3
0.050
Why?
Glaucoma
1
1987
250
0.050
Why?
Regression Analysis
1
2006
1001
0.050
Why?
Psychiatric Status Rating Scales
2
2017
531
0.050
Why?
Proteins
1
2010
1023
0.050
Why?
Apoptosis
2
2015
2440
0.050
Why?
Biopsy
2
2019
1082
0.050
Why?
Area Under Curve
2
2017
331
0.050
Why?
Immunoglobulins, Intravenous
1
2024
133
0.050
Why?
Acute Disease
1
2026
1036
0.050
Why?
Anger
1
2023
60
0.050
Why?
HLA-DR Antigens
1
2023
220
0.050
Why?
Lactate Dehydrogenases
1
2022
5
0.050
Why?
Risk
3
2010
919
0.050
Why?
Statistics, Nonparametric
2
2017
428
0.050
Why?
Thymidylate Synthase
1
2002
13
0.050
Why?
Syndrome
1
2023
381
0.050
Why?
Creatine Kinase
1
2022
72
0.050
Why?
Cell Line, Tumor
2
2007
3542
0.050
Why?
Body Weight
2
2021
971
0.040
Why?
Gene Expression Regulation
1
2011
2597
0.040
Why?
Organ Size
2
2014
461
0.040
Why?
Agraphia
1
2021
1
0.040
Why?
Patient Selection
1
2006
738
0.040
Why?
Ki-67 Antigen
1
2002
117
0.040
Why?
Hematologic Diseases
2
2014
66
0.040
Why?
L-Lactate Dehydrogenase
2
2013
112
0.040
Why?
Confusion
1
2021
30
0.040
Why?
Aphasia
1
2021
24
0.040
Why?
Pain
3
2014
789
0.040
Why?
Uric Acid
1
2022
167
0.040
Why?
Wounds and Injuries
1
2009
961
0.040
Why?
Cell Cycle Proteins
1
2005
630
0.040
Why?
Clinical Trials as Topic
1
2006
1061
0.040
Why?
DNA-Binding Proteins
1
2008
1480
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2022
167
0.040
Why?
Glass
2
2009
46
0.040
Why?
Stem Cells
1
2005
628
0.040
Why?
Galvanic Skin Response
1
2020
26
0.040
Why?
Radiotherapy
1
2021
204
0.040
Why?
In Situ Hybridization, Fluorescence
1
2021
325
0.040
Why?
Serum Albumin
1
2021
147
0.040
Why?
Electroshock
1
2020
145
0.040
Why?
Creatinine
1
2022
515
0.040
Why?
Disease Susceptibility
1
2022
344
0.040
Why?
Manitoba
1
2000
4
0.040
Why?
Benzylamines
2
2012
44
0.040
Why?
Receptors, Antigen, T-Cell
1
2023
673
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2026
992
0.040
Why?
Transplantation, Homologous
2
2013
418
0.040
Why?
Colonic Neoplasms
1
2002
257
0.040
Why?
Age Factors
2
2021
3342
0.040
Why?
Vinblastine
1
2019
75
0.040
Why?
Dacarbazine
1
2019
100
0.040
Why?
Vero Cells
2
2010
83
0.040
Why?
Medication Errors
1
2000
85
0.040
Why?
Neoplasm Invasiveness
1
2021
506
0.040
Why?
Amino Acid Substitution
1
2019
302
0.040
Why?
Administration, Oral
2
2012
866
0.040
Why?
Antibodies, Viral
1
2023
674
0.040
Why?
Cluster Analysis
2
2014
500
0.040
Why?
Intravitreal Injections
1
2018
71
0.040
Why?
Immunoglobulin G
1
2023
892
0.030
Why?
Gamma Rays
1
2018
57
0.030
Why?
Injections, Intravenous
1
2018
197
0.030
Why?
Aging
1
2009
1969
0.030
Why?
Blotting, Western
2
2015
1179
0.030
Why?
Hospitals, Teaching
1
2018
120
0.030
Why?
Chi-Square Distribution
2
2010
527
0.030
Why?
Anthracyclines
1
2018
49
0.030
Why?
Brain Neoplasms
1
2007
1329
0.030
Why?
Tumor Suppressor Protein p53
1
2002
534
0.030
Why?
Bleomycin
1
2019
255
0.030
Why?
Nursing Homes
1
2000
174
0.030
Why?
Seizures
1
2022
483
0.030
Why?
Water Movements
1
2017
28
0.030
Why?
Bendamustine Hydrochloride
1
2017
18
0.030
Why?
Plasma Exchange
1
2017
18
0.030
Why?
United Kingdom
1
2018
344
0.030
Why?
Organoplatinum Compounds
1
2017
65
0.030
Why?
Etoposide
2
2008
168
0.030
Why?
Infant
3
2024
10077
0.030
Why?
Rain
1
2017
39
0.030
Why?
Immunoglobulin M
1
2018
265
0.030
Why?
Cell Count
2
2009
319
0.030
Why?
Dose-Response Relationship, Drug
2
2011
2028
0.030
Why?
Cell Separation
2
2010
305
0.030
Why?
Animals
8
2015
38030
0.030
Why?
Green Fluorescent Proteins
2
2010
407
0.030
Why?
Neoplasms, Radiation-Induced
1
2017
100
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2011
749
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
161
0.030
Why?
Image Processing, Computer-Assisted
2
2011
779
0.030
Why?
Intensive Care Units
1
2022
924
0.030
Why?
Neutropenia
1
2017
154
0.030
Why?
Particle Size
1
2017
381
0.030
Why?
Blood-Retinal Barrier
1
1996
13
0.030
Why?
von Hippel-Lindau Disease
1
1996
12
0.030
Why?
Retina
1
2018
326
0.030
Why?
Acoustic Stimulation
1
2017
333
0.030
Why?
Fundus Oculi
1
1996
89
0.030
Why?
Chemotherapy, Adjuvant
1
2017
423
0.030
Why?
Registries
2
2017
2406
0.030
Why?
Functional Neuroimaging
1
2015
59
0.030
Why?
Extracellular Space
1
1996
117
0.030
Why?
Models, Theoretical
1
2018
558
0.030
Why?
Mechanistic Target of Rapamycin Complex 2
1
2015
62
0.030
Why?
Foot
1
2016
103
0.030
Why?
Cross-Sectional Studies
2
2017
5905
0.030
Why?
Adenine
1
2017
339
0.030
Why?
France
1
2014
40
0.030
Why?
Ankle Joint
1
2016
122
0.030
Why?
Analysis of Variance
2
2009
1300
0.030
Why?
Anxiety
1
2022
1118
0.030
Why?
Clone Cells
1
2014
263
0.030
Why?
Polyradiculoneuropathy
1
2013
5
0.030
Why?
Paraneoplastic Syndromes, Nervous System
1
2013
14
0.030
Why?
Mitral Valve Insufficiency
1
2014
68
0.030
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
20
0.030
Why?
Guillain-Barre Syndrome
1
2013
23
0.030
Why?
Ambulatory Care
1
2018
609
0.020
Why?
Transfection
2
2006
926
0.020
Why?
Sciatic Nerve
1
2013
62
0.020
Why?
Tumor Cells, Cultured
1
2015
886
0.020
Why?
Immunoassay
1
2014
109
0.020
Why?
In Vitro Techniques
1
2015
1048
0.020
Why?
Survival
1
2013
38
0.020
Why?
Lymphatic Metastasis
1
2014
331
0.020
Why?
Immunoenzyme Techniques
1
2013
200
0.020
Why?
Patient Reported Outcome Measures
1
2017
497
0.020
Why?
Device Removal
1
2014
142
0.020
Why?
In Situ Hybridization
1
2013
318
0.020
Why?
Medical Records
1
2013
192
0.020
Why?
Heart Valve Prosthesis
1
2014
129
0.020
Why?
Vision, Binocular
1
1993
47
0.020
Why?
Psychomotor Performance
1
2015
324
0.020
Why?
Plasmacytoma
1
2012
19
0.020
Why?
Transcription, Genetic
2
2011
1454
0.020
Why?
Brachytherapy
1
2013
132
0.020
Why?
Neuropsychological Tests
1
2017
1134
0.020
Why?
Horner Syndrome
1
1992
7
0.020
Why?
Heart Valve Prosthesis Implantation
1
2014
198
0.020
Why?
False Positive Reactions
1
2012
123
0.020
Why?
Research Design
1
2018
1137
0.020
Why?
Gastrointestinal Diseases
1
2014
221
0.020
Why?
Explosions
1
1991
14
0.020
Why?
Hippocampus
2
2009
971
0.020
Why?
Farnesyltranstransferase
1
2011
21
0.020
Why?
Costs and Cost Analysis
1
2012
221
0.020
Why?
Diagnostic Imaging
1
2014
337
0.020
Why?
Food Labeling
1
1991
11
0.020
Why?
Diagnostic Techniques, Ophthalmological
1
2011
53
0.020
Why?
Tomography, Optical Coherence
1
2013
271
0.020
Why?
Immunologic Techniques
1
2011
38
0.020
Why?
Interleukin-1beta
1
2013
389
0.020
Why?
Databases, Factual
1
2017
1490
0.020
Why?
RNA Splicing Factors
1
2011
66
0.020
Why?
Blood Viscosity
1
2010
19
0.020
Why?
Psychometrics
1
2015
731
0.020
Why?
Phosphorylation
1
2015
1707
0.020
Why?
Iowa
1
2010
31
0.020
Why?
Plasmapheresis
1
2010
24
0.020
Why?
Secondary Prevention
1
2012
251
0.020
Why?
Intelligence Tests
1
2010
55
0.020
Why?
Gastrointestinal Tract
1
2013
204
0.020
Why?
Prostaglandin Antagonists
1
1990
3
0.020
Why?
Cells, Cultured
2
2010
4148
0.020
Why?
Drug Therapy, Combination
2
2010
1044
0.020
Why?
Silicon
1
2010
19
0.020
Why?
Early Medical Intervention
1
2010
62
0.020
Why?
Frontal Lobe
1
2011
160
0.020
Why?
Syk Kinase
1
2009
19
0.020
Why?
Transplantation Chimera
1
2010
57
0.020
Why?
Exons
1
2011
363
0.020
Why?
Cannabinoid Receptor Antagonists
1
2009
1
0.020
Why?
Receptors, Cannabinoid
1
2009
13
0.020
Why?
Accidents, Home
1
2009
33
0.020
Why?
Poisson Distribution
1
2009
78
0.020
Why?
Administration, Topical
1
1990
153
0.020
Why?
Equipment Failure Analysis
1
2010
124
0.020
Why?
Boston
1
2009
93
0.020
Why?
Ophthalmic Solutions
1
1990
80
0.020
Why?
Medulla Oblongata
1
2009
37
0.020
Why?
Tissue Distribution
1
2010
335
0.020
Why?
Mice, SCID
1
2010
369
0.020
Why?
Inflammation
1
2021
2878
0.020
Why?
Statistics as Topic
1
2010
283
0.020
Why?
Periaqueductal Gray
1
2009
37
0.020
Why?
Lacerations
1
2009
40
0.020
Why?
Formaldehyde
1
2009
65
0.020
Why?
Endophthalmitis
1
1989
46
0.020
Why?
Random Allocation
1
1990
365
0.020
Why?
White Matter
1
2011
153
0.020
Why?
Tumor Burden
1
2010
325
0.020
Why?
Macular Edema
1
1989
49
0.020
Why?
Catheters, Indwelling
1
2009
96
0.020
Why?
Vision Disorders
1
1991
179
0.020
Why?
Morpholines
1
2009
130
0.020
Why?
Cataract
1
1992
238
0.020
Why?
Aminopyridines
1
2009
129
0.020
Why?
Atrophy
1
2009
199
0.020
Why?
Alternative Splicing
1
2011
247
0.020
Why?
Proto-Oncogene Proteins c-fos
1
2009
196
0.020
Why?
Rats
2
2009
5584
0.020
Why?
Prevalence
1
2016
2865
0.020
Why?
Intraoperative Complications
1
1990
157
0.020
Why?
Bone Marrow
1
2010
306
0.020
Why?
Factor Analysis, Statistical
1
2009
291
0.020
Why?
Diarrhea
1
2009
193
0.020
Why?
Sulfur Hexafluoride
1
1988
2
0.020
Why?
Mucositis
1
2008
20
0.020
Why?
Prednisolone
1
1988
67
0.020
Why?
Chromatography, Liquid
1
2010
450
0.020
Why?
Foreign Bodies
1
2009
110
0.020
Why?
Methods
1
1988
68
0.020
Why?
Hot Temperature
1
1991
396
0.020
Why?
Tumor Necrosis Factor-alpha
1
2013
1217
0.020
Why?
Orbital Diseases
1
1988
37
0.020
Why?
Blindness
1
1988
51
0.020
Why?
Air
1
1988
44
0.020
Why?
Lymphocyte Subsets
1
2008
77
0.020
Why?
Equipment Design
1
2010
525
0.020
Why?
Polyethylenes
1
2008
12
0.020
Why?
Silicones
1
2008
31
0.020
Why?
Vasculitis
1
1988
69
0.020
Why?
Polytetrafluoroethylene
1
2008
23
0.020
Why?
Purine-Nucleoside Phosphorylase
1
2007
6
0.020
Why?
Membrane Cofactor Protein
1
2007
14
0.020
Why?
Up-Regulation
1
2011
847
0.020
Why?
Pneumonia
1
2014
636
0.020
Why?
Sequence Deletion
1
2008
190
0.020
Why?
Vitreous Hemorrhage
1
1987
10
0.020
Why?
Leukocytes, Mononuclear
1
2010
574
0.020
Why?
Enzyme Inhibitors
1
2011
820
0.020
Why?
Timolol
1
1987
14
0.020
Why?
Pilocarpine
1
1987
16
0.020
Why?
Ifosfamide
1
2007
39
0.020
Why?
Infant, Low Birth Weight
1
2008
156
0.020
Why?
Gene Rearrangement
1
2008
155
0.020
Why?
Infant, Newborn
2
2010
6447
0.020
Why?
RNA-Binding Proteins
1
2011
447
0.020
Why?
Prodrugs
1
2007
52
0.020
Why?
Lymph Nodes
1
2010
503
0.020
Why?
Drug Therapy
1
2007
84
0.020
Why?
Adrenal Cortex Hormones
1
2010
484
0.020
Why?
Xenograft Model Antitumor Assays
1
2010
934
0.020
Why?
Tandem Mass Spectrometry
1
2010
572
0.020
Why?
Pain Measurement
1
2009
561
0.020
Why?
Carboplatin
1
2007
162
0.020
Why?
Birth Weight
1
2010
514
0.020
Why?
Prostheses and Implants
1
2008
137
0.020
Why?
Trabeculectomy
1
1987
75
0.020
Why?
Cell Growth Processes
1
2006
48
0.020
Why?
Neoplasm Metastasis
1
1989
688
0.020
Why?
Cerebral Hemorrhage
1
2007
125
0.020
Why?
Legislation as Topic
1
1986
5
0.020
Why?
Gestational Age
1
2010
987
0.020
Why?
Injections
1
2007
199
0.020
Why?
Immunocompetence
1
2006
46
0.010
Why?
Enteral Nutrition
1
2008
217
0.010
Why?
Mice
3
2010
18329
0.010
Why?
Epidemiologic Methods
1
2006
91
0.010
Why?
Choroid Neoplasms
1
1986
9
0.010
Why?
Comorbidity
1
2011
1661
0.010
Why?
Phenotype
1
2014
3155
0.010
Why?
Stress, Mechanical
1
1988
494
0.010
Why?
Attention Deficit Disorder with Hyperactivity
1
2010
429
0.010
Why?
Rabbits
1
2007
652
0.010
Why?
Gene Silencing
1
2006
202
0.010
Why?
Imaging, Three-Dimensional
1
2009
583
0.010
Why?
Tritium
1
2005
67
0.010
Why?
Myelin Basic Protein
1
2005
44
0.010
Why?
Thymidine
1
2005
60
0.010
Why?
Nestin
1
2005
19
0.010
Why?
Bromodeoxyuridine
1
2005
77
0.010
Why?
Intermediate Filament Proteins
1
2005
57
0.010
Why?
Accidents, Traffic
1
1986
193
0.010
Why?
Pregnancy
2
2010
7202
0.010
Why?
Glial Fibrillary Acidic Protein
1
2005
122
0.010
Why?
RNA Interference
1
2006
475
0.010
Why?
Transcriptional Activation
1
2006
372
0.010
Why?
Embryo, Mammalian
1
2005
234
0.010
Why?
Genome-Wide Association Study
1
2011
1407
0.010
Why?
Software
1
2009
680
0.010
Why?
Microtubule-Associated Proteins
1
2005
194
0.010
Why?
Cannabis
1
2011
509
0.010
Why?
Adenoviridae Infections
3
1958
20
0.010
Why?
Biocompatible Materials
1
2008
429
0.010
Why?
Infant, Premature
1
2008
619
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
977
0.010
Why?
Mice, Transgenic
1
2007
2188
0.010
Why?
Length of Stay
1
2008
1349
0.010
Why?
Bed Rest
1
1981
14
0.010
Why?
Pediatrics
1
2010
1121
0.010
Why?
Antimetabolites, Antineoplastic
1
2002
106
0.010
Why?
Immobilization
1
1981
54
0.010
Why?
Recovery of Function
1
2006
716
0.010
Why?
Joints
1
1982
106
0.010
Why?
Bupivacaine
1
1981
40
0.010
Why?
Colectomy
1
2002
106
0.010
Why?
Nerve Tissue Proteins
1
2005
591
0.010
Why?
Disease Models, Animal
1
2011
4560
0.010
Why?
Hypertension
1
2009
1273
0.010
Why?
Oculomotor Muscles
1
1981
86
0.010
Why?
Suture Techniques
1
1981
137
0.010
Why?
Adenoviridae
2
1958
199
0.010
Why?
Movement
1
1982
293
0.010
Why?
Gene Expression
1
2005
1476
0.010
Why?
Light Coagulation
1
1980
10
0.010
Why?
HeLa Cells
2
1958
632
0.010
Why?
Rats, Sprague-Dawley
1
2005
2524
0.010
Why?
Preoperative Care
1
1981
380
0.010
Why?
Emergency Service, Hospital
1
2009
2381
0.010
Why?
Diabetic Retinopathy
1
1980
209
0.010
Why?
RNA, Messenger
1
2005
2803
0.010
Why?
Cryotherapy
1
1996
21
0.010
Why?
Laser Coagulation
1
1996
80
0.010
Why?
Mice, Inbred C57BL
1
2005
5983
0.010
Why?
Diabetes Mellitus
1
1982
1097
0.010
Why?
Polyarteritis Nodosa
1
1988
11
0.000
Why?
Virus Diseases
2
1956
216
0.000
Why?
Kidney Failure, Chronic
1
1988
599
0.000
Why?
Hand
1
1982
157
0.000
Why?
Adenovirus Vaccines
1
1958
2
0.000
Why?
Models, Biological
1
1986
1764
0.000
Why?
Neutralization Tests
1
1956
76
0.000
Why?
Antibody Formation
1
1956
288
0.000
Why?
Viruses
1
1956
165
0.000
Why?
Cell Culture Techniques
1
1956
372
0.000
Why?
Johnston's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)